CNS Pharmaceuticals (CNSP) has priced its initial public offering of 2.125M shares of common stock at $4.00 per share, gross proceeds expected to be $8.5M.
Underwriters over-allotment is an additional 318,750 shares.
The common stock is expected to begin trading today on the NASDAQ Capital Market.
The offering is expected to close on November 13.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.